Form4insider filings, from the source

SEC Form 4 · accession 0000899243-18-008309

Myovant Sciences Ltd. · MYOV

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owners
A/S Takeda
10% Owner
Period of report
Mar 19, 2018
Accepted (ET)
Mar 21, 2018 · 9:42 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001679082

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common StockF1,F2Mar 19, 2018S7,420,625$18.67D0D
Common StockF1,F2Mar 19, 2018P7,420,625$18.67A7,420,625IBy Millennium Pharmaceuticals , Inc.

Table II — derivative securities

No Table II lines on this filing.

Explanation of responses

Remarks

Exhibit List: Exhibit 24.1 Power of Attorney for Takeda Pharmaceuticals International AG; Exhibit 24.2 Power of Attorney for Takeda Pharmaceuticals Company Limited; Exhibit 24.3 Power of Attorney for Takeda A/S (Denmark); Exhibit 24.4 Power of Attorney for Takeda Europe Holdings B.V. (Netherlands); Exhibit 24.5 Power of Attorney for Takeda Pharma A/S (Denmark).